Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Collegium Pharmaceutical ...

    NASDAQ: COLL · Real-Time Price · USD
    29.15
    -0.03 (-0.10%)
    At close: May 30, 2025, 3:59 PM
    29.14
    -0.03%
    After-hours: May 30, 2025, 04:21 PM EDT
    -0.10%
    Bid 28.04
    Market Cap 936.95M
    Revenue (ttm) 664.28M
    Net Income (ttm) 43.89M
    EPS (ttm) 1.22
    PE Ratio (ttm) 23.89
    Forward PE 4.16
    Analyst Buy
    Ask 32.6
    Volume 118,543
    Avg. Volume (20D) 386,038
    Open 29.14
    Previous Close 29.18
    Day's Range 28.91 - 29.50
    52-Week Range 23.23 - 42.29
    Beta 0.63

    About COLL

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol COLL
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for COLL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Why Price Moved

    Why Price Moved is a one-sentence explanation of why a stock is moving higher or down. By removing noise and collecting signals from news, press releases and SEC filings, we can pinpoint the trigger for price movements.
    3 months ago
    +2.22%
    Collegium Pharmaceuticals shares are trading highe... Unlock content with Pro Subscription
    3 months ago
    +0.25%
    Collegium Pharmaceuticals shares are trading higher after the company reported better-than-expected Q4 financial results.
    news image

    3 weeks ago · seekingalpha.com

    Collegium Pharmaceutical, Inc. (COLL) Q1 2025 Earnings Call Transcript

    Call Start: 16:30 January 1, 0000 5:05 PM ET Collegium Pharmaceutical, Inc. (NASDAQ:COLL ) Q1 2025 Earnings Call May 8, 2025 16:30 ET Company Participants Ian Karp - Head, Investor Relations Vikram Ka...

    news image

    3 weeks ago · zacks.com

    Compared to Estimates, Collegium Pharmaceutical (COLL) Q1 Earnings: A Look at Key Metrics

    The headline numbers for Collegium Pharmaceutical (COLL) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wal...

    news image

    3 weeks ago · zacks.com

    Collegium Pharmaceutical (COLL) Q1 Earnings and Revenues Surpass Estimates

    Collegium Pharmaceutical (COLL) came out with quarterly earnings of $1.49 per share, beating the Zacks Consensus Estimate of $1.43 per share. This compares to earnings of $1.45 per share a year ago.

    news image

    1 month ago · zacks.com

    Collegium Pharmaceutical (COLL) Expected to Beat Earnings Estimates: Should You Buy?

    Collegium Pharmaceutical (COLL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

    news image

    1 month ago · zacks.com

    Is Collegium Pharmaceutical (COLL) Stock Undervalued Right Now?

    Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

    news image

    2 months ago · seekingalpha.com

    Collegium Pharmaceutical's Shareholders Might Be In For A Pain-Free 2025

    Collegium Pharmaceutical Inc. is a specialty pharma company with strong cash flow, high EBITDA margins, and a focus on non-abusive painkillers and ADHD drugs. The new CEO has a proven track record, pr...

    Add to Watchlist